1-3 of 3
Manuel Pérez-Encinas
Close
Sort by
Journal Articles

Hypophosphatemia During Imatinib Treatment of Newly Diagnosed Chronic Myeloid Leukemia Patients Is Associated with Better Response.

Luis Felipe Casado, MD, PhD, Isabel Massague, MD, Pilar Giraldo, MD, Manuel Pérez-Encinas, MD, Raquel de Paz, MD, PhD, Joaquin Martínez-López, MD, PhD, Rafael Fores, MD, Santiago Osorio, MD, Maria José Requena, MD, Luis Palomera, MD, María Jesus Peñarrubia, MD, Carmen Burgaleta, MD, PhD, Begoña Maestro, PhD, Juan Luis Steegmann, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1121.
https://doi.org/10.1182/blood.V114.22.1121.1121
Published: 2009
Journal Articles

Study of the Relation Between the Time Course of the JAK2V617F Allele Burden and the Clinical Evolution in Patients with Myeloproliferative Neoplasms (MPN); A Single Center Study

Marta Anna Sobas, Manuel Pérez-Encinas, Celsa Quinteiro, Teresa González, Sandra Suaréz, Natalia Alonso, José Díaz, Angeles Bendaña, Marta Sonia González, Jose-Luis Bello
Journal: Blood
Blood (2008) 112 (11): 5250.
https://doi.org/10.1182/blood.V112.11.5250.5250
Published: 2008
Journal Articles

Autologous Stem Cell Transplantation after FLAG-IDA Chemotherapy for High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemias Secondary to MDS (sAML) Does Not Improve Outcome: A PETHEMA Experience in 103 Patients.

Guillermo F. Sanz, MD, Armando V. Mena-Duran, MD, Jose M. Ribera, MD, Teresa Bernal, MD, Luis Palomera, MD, Maria C. del Cañizo, MD, Mar Tormo, MD, Maria J. Sayas, MD, Raimundo García-Boyero, MD, Javier de la Serna, MD, Manuel Pérez-Encinas, MD, Montserrat Pérez-Sánchez, MD, María J. Arilla, MD, Juan J. Moneva, MD, Maria L. Amigo, MD, Luis Benlloch, Montserrat Batlle, MD, Consuelo Rayon, MD
Journal: Blood
Blood (2005) 106 (11): 793.
https://doi.org/10.1182/blood.V106.11.793.793
Published: 2005